Where does the data come from?

openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list). Official record: https://dps.fda.gov/drugshortages

Teva Pharmaceuticals USA, Inc.: Metoprolol Succinate Tablet, Extended Release to be discontinued

Q: How to monitor Teva Pharmaceuticals USA, Inc. and peer cardiovascular records

DrugShortagePulse lists new DrugShortagePulse records from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) as they are published; a free weekly email digest and paid alerts follow records like this one.

Teva Pharmaceuticals USA, Inc.: Metoprolol Succinate Tablet, Extended Release to be discontinued. Its amount of 7 is top-decile (91st percentile of 353 records). Dated 66 days ago, it serves as a historical benchmark. Score 50/100. As of 2026-11-04, from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).

Data as of 2026-11-04 · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)

amount: 7 · 91th percentile of 353 DrugShortagePulse records · 2.3x the median

Free preview: all 12 published fields of this record are shown below. Locked: 352 related DrugShortagePulse records and the 5-column CSV export.

Field	Value
Manufacturer	Teva Pharmaceuticals USA, Inc.
Drug	Metoprolol Succinate Tablet, Extended Release
Dosage form	Tablet
Therapeutic category	Cardiovascular
Status	To Be Discontinued
Stage	Manufacturer discontinuation
Presentations affected	7
Package NDCs	45963-676-11, 45963-678-11, 45963-709-96, 45963-677-96, 45963-677-11, 45963-709-11, 45963-676-96
Manufacturer supply note	A business decision was made to discontinue manufacture of the drug.
Discontinued date	2026-08-31
First posted	2026-08-31
Updated	2026-08-31
amount percentile	91th of 353 (median 3, 2.3x median)
Peer records CSV (353 records)	🔒 Click to unlock →
CRM-ready export with official source URLs	🔒 Click to unlock →

View the official record

Markdown version

Watch Teva Pharmaceuticals USA, Inc.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock Teva Pharmaceuticals USA + all 353 records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Manufacturer · Drug · Stage · Availability · Updated · official source URL

Source agency: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
Record date: 2026-08-31
Data refreshed: 2026-11-04
Refunds on request within 14 days

Search all records free →

Top DrugShortagePulse records: Sanofi-Aventis U.S. LLC · Fresenius Kabi USA, LLC · Hospira, Inc., a Pfizer Company · Fresenius Kabi USA, LLC · Hospira, Inc., a Pfizer Company · Browse all by state and category →

LIVE PUBLIC DATA Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) · Last refreshed: Wed, 04 Nov 2026 06:10:12 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

<a href="https://zalwin.com/report/drugshortagepulse/drugshort-teva-pharmaceuticals-usa-inc-%7Cmetoprolol-succinate-tablet-extended-release%7Cto-be-discontinued" rel="noopener"><img src="https://zalwin.com/badge/listed.svg" alt="Teva Pharmaceuticals USA, Inc. on Zalwin public records" width="150" height="28"></a>

50 / 100 Score

The manufacturer is leaving the market.

What is the DrugShortagePulse record for Teva Pharmaceuticals USA, Inc.?

Teva Pharmaceuticals USA, Inc.'s Metoprolol Succinate Tablet, Extended Release is on the FDA drug shortage list. Manufacturer discontinuation. Last updated 2026-08-31.

How does Teva Pharmaceuticals USA, Inc. compare to other DrugShortagePulse records?

This is a top-decile record: its amount of 7 is 2.3x the median of 3 across 353 records. It is 66 days old; check the official source for later updates before acting.

Teva Pharmaceuticals USA, Inc. vs. top 3 peers

Organization	Amount	Percentile	Record date
Teva Pharmaceuticals USA, Inc.	7	91st	2026-08-31
Baxter Healthcare	3	62nd	2026-10-30
Baxter Healthcare	2	49th	2026-10-30
Baxter Healthcare	2	49th	2026-10-30

How to monitor Teva Pharmaceuticals USA, Inc. and peer cardiovascular records

Get new DrugShortagePulse records like Teva Pharmaceuticals USA, Inc. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new shortages in your categories

DrugShortagePulse emails new and changed FDA drug shortages matching your therapeutic categories.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.